Suppr超能文献

自发药物不良反应报告的局限性与障碍:两例“具有挑战性的”病例报告

Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports.

作者信息

Palleria Caterina, Leporini Christian, Chimirri Serafina, Marrazzo Giuseppina, Sacchetta Sabrina, Bruno Lucrezia, Lista Rosaria M, Staltari Orietta, Scuteri Antonio, Scicchitano Francesca, Russo Emilio

机构信息

Department of Science of Health, School of Medicine, University of Catanzaro, Italy and Pharmacovigilance's Centre Calabria Region, University Hospital Mater Domini, Catanzaro, Italy.

Azienda Sanitaria Provinciale di Cosenza, Farmacovigilanza Territorio Paola, Italy.

出版信息

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S66-72. doi: 10.4103/0976-500X.120955.

Abstract

INTRODUCTION

Nowadays, based on several epidemiological data, iatrogenic disease is an emerging public health problem, especially in industrialized countries. Adverse drugs reactions (ADRs) are extremely common and, therefore, clinically, socially, and economically worthy of attention. Spontaneous reporting system for suspected ADRs represents the cornerstone of the pharmacovigilance, because it allows rapid detection of potential alarm signals related to drugs use. However, spontaneous reporting system shows several limitations, which are mainly related to under-reporting. In this paper, we describe two particular case reports, which emphasize some reasons of under-reporting and other common criticisms of spontaneous reporting systems.

MATERIALS AND METHODS

We performed a computer-aided search of Medline, PubMed, Embase, Cochrane library databases, national and international databases of suspected ADRs reports in order to identify previous published case reports and spontaneous reports about the ADRs reviewed in this paper, and to examine the role of suspected drugs in the pathogenesis of the described adverse reactions.

RESULTS

First, we reported a case of tizanidine-induced hemorrhagic cystitis. In the second case report, we presented an episode of asthma exacerbation after taking bimatoprost. Through the review of these two cases, we highlighted some common criticisms of spontaneous reporting systems: under-reporting and false causality attribution.

DISCUSSION AND CONCLUSION

Healthcare workers sometimes do not report ADRs because it is challenging to establish with certainty the causal relationship between drug and adverse reaction; however, according to a key principle of pharmacovigilance, it is always better to report even a suspicion to generate an alarm in the interest of protecting public health.

摘要

引言

如今,基于多项流行病学数据,医源性疾病是一个新出现的公共卫生问题,尤其是在工业化国家。药物不良反应极为常见,因此在临床、社会和经济方面都值得关注。疑似药物不良反应自发报告系统是药物警戒的基石,因为它能快速检测与药物使用相关的潜在警示信号。然而,自发报告系统存在一些局限性,主要与报告不足有关。在本文中,我们描述了两例特殊病例报告,强调了报告不足的一些原因以及对自发报告系统的其他常见批评。

材料与方法

我们对Medline、PubMed、Embase、Cochrane图书馆数据库、国家和国际疑似药物不良反应报告数据库进行了计算机辅助检索,以识别先前发表的与本文所综述的药物不良反应相关的病例报告和自发报告,并研究疑似药物在所描述不良反应发病机制中的作用。

结果

首先,我们报告了一例替扎尼定诱发的出血性膀胱炎病例。在第二例病例报告中,我们呈现了一例使用比马前列素后哮喘加重的情况。通过对这两例病例的回顾,我们强调了对自发报告系统的一些常见批评:报告不足和错误的因果关系归因。

讨论与结论

医护人员有时不报告药物不良反应,因为确定药物与不良反应之间的因果关系具有挑战性;然而,根据药物警戒的一项关键原则,即使只是怀疑也最好报告,以便发出警报,保护公众健康。

相似文献

1
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports.
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S66-72. doi: 10.4103/0976-500X.120955.
3
Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
S Afr Med J. 2020 Nov 27;110(12):1226-1230. doi: 10.7196/SAMJ.2020.v110i12.14721.
6
Monitoring drug safety in Astrakhan, Russia.
Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680.
7
Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Drug Saf. 2006;29(12):1163-72. doi: 10.2165/00002018-200629120-00007.
9
The value of patient reporting to the pharmacovigilance system: a systematic review.
Br J Clin Pharmacol. 2017 Feb;83(2):227-246. doi: 10.1111/bcp.13098. Epub 2016 Oct 12.
10
Drug-related deaths: an analysis of the Italian spontaneous reporting database.
Drug Saf. 2008;31(8):703-13. doi: 10.2165/00002018-200831080-00007.

引用本文的文献

1
2
New Function for Safety Signal Monitoring in MID-NET: The Case of an Anti-COVID-19 Drug.
Clin Transl Sci. 2025 Apr;18(4):e70208. doi: 10.1111/cts.70208.
3
The UK's Early Access to Medicines Scheme 10 years on: an evaluation using publicly available data.
JRSM Open. 2025 Feb 24;16(2):20542704251317916. doi: 10.1177/20542704251317916. eCollection 2025 Feb.

本文引用的文献

1
Pharmacovigilance in Italy: An overview.
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S20-8. doi: 10.4103/0976-500X.120942.
2
Glaucoma medications.
Insight. 2013 Winter;38(1):5-9; quiz 10.
3
Bimatoprost protects retinal neuronal damage via Akt pathway.
Eur J Pharmacol. 2013 Feb 28;702(1-3):56-61. doi: 10.1016/j.ejphar.2013.01.038. Epub 2013 Feb 6.
4
Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.
Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:109-21. doi: 10.1016/j.prostaglandins.2013.01.001. Epub 2013 Jan 23.
6
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).
Eur J Clin Pharmacol. 2013 Feb;69(2):237-44. doi: 10.1007/s00228-012-1321-7. Epub 2012 Jun 17.
7
Tizanidine for alcohol withdrawal treatment.
Med Hypotheses. 2011 Oct;77(4):548-9. doi: 10.1016/j.mehy.2011.06.028. Epub 2011 Jul 5.
8
Vaginal misoprostol for cervical ripening and induction of labour.
Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD000941. doi: 10.1002/14651858.CD000941.pub2.
9
Managing spasticity with drugs.
Eur J Phys Rehabil Med. 2010 Sep;46(3):401-10.
10
Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.
Am J Health Syst Pharm. 2010 Oct 1;67(19):1606-10. doi: 10.2146/ajhp090657.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验